Marine sediment metagenome
Ontology highlight
ABSTRACT:
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| DRR139005.fastq.gz | Fastqsanger.gz | |||
| DRR139006.fastq.gz | Fastqsanger.gz | |||
| DRR139007.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 3 of 3 |
Similar Datasets
Project description:Studies on temporal changes in the sediment oxygen consumption and bacterial community structure in a seasonally hypoxic enclosed bay, Omura Bay
| PRJDB7388 | ENA
Project description:Ethane-degrading sulfate-reducing enrichment culture
| PRJNA495932 | ENA
Project description:Response of sedimentary oxygen consumption and bacterial community composition to temporal re-oxygenation in a seasonally hypoxic enclosed bay
| PRJDB8597 | ENA
Project description:eDNA from sediments of the Otsuchi Bay
| PRJDB10838 | ENA
Project description:Environmental Control of Iron Reducing Microorganisms in Antarctic Sediments (ECIMAS)
| PRJNA668691 | ENA
Project description:Microbial Diversity in Antarctic marine sediments (Admiralty Bay and Bransfield Strait)
| PRJNA335729 | ENA
Project description:Aquifer sediment nitrate reducing community change
| PRJNA209710 | ENA
Project description:Assessing the diversity of benthic sulfate-reducing bacteria in Northwestern Gulf of Mexico by Illumina sequencing of dsrB gene
| PRJNA626626 | ENA
Project description:Microbial community analysis in sediments from Tsukumo bay determined by 16S rRNA gene amplicon sequencing
| PRJDB16928 | ENA
Project description:The activation of the transcription factor Hypoxia-inducible factor-1 (HIF-1) plays an essential role in tumor development, tumor progression and resistance to chemo- and radiotherapy. In order to identify compounds targeting the HIF pathway, a small-molecule library was screened using a luciferase-driven HIF-1 reporter cell line under hypoxia. The high throughput screen led to the identification of a class of aminoalkyl-substituted compounds that inhibited hypoxia-induced HIF-1 target gene expression in human lung cancer cell lines at low nanomolar concentrations but did not affect expression levels of genes outside of the HIF-1 pathway. Lead structure BAY 87-2243 was found to inhibit HIF-1α protein accumulation under hypoxic conditions in NSCLC cell line H460 but had no effect on HIF-1α protein accumulation and HIF target gene expression in RCC4 cells lacking VHL activity or in H460 cells after inhibition of HIF prolyl hydroxylase activity. BAY 87-2243 had no effect on HIF-α-mRNA levels. Antitumor activity of BAY 87-2243 and suppression of HIF-1 target gene expression in vivo was demonstrated in a H460 xenograft model. BAY 87-2243 did not inhibit cell proliferation under standard conditions. However under glucose depletion, a condition favoring mitochondrial ATP generation as energy source, BAY 87-2243 inhibited cell proliferation in the nanomolar range. Further experiments revealed that BAY 87-2243 inhibits mitochondrial production of reactive oxygen species (ROS) by blocking complex I activity but has no effect on complex III activity. Lowering of mitochondrial ROS production to reduce hypoxia-induced HIF-1 activity in tumors might be an interesting therapeutic approach to overcome chemo- and radiotherapy-resistance of hypoxic tumors. We used microarrays to detail the global programme of gene expression that is induced in NSCLC cell line H460 upon hypoxia (16 h incubation at 1 % pO2) and evaluated a dose-dependent effect of our HIF-1-pathway inhibitor BAY 87-2243 on genes tthat are affected by hypoxia. Specificity of BAY 87-2243 for the suppression of HIF-1-mediated gene transcription on a genome-wide scale was evaluated by microarray hybridizations using Affymetrix GeneChip Human Gene 1.0 ST arrays. RNA from normoxic H460 cells and from hypoxic H460 cells incubated with 1, 10 and 100 nM BAY 87-2243 respectively was subjected to array hybridization. Of those 30 genes that were most strongly suppressed by 100 nM BAY 87-2243 in hypoxic H460 cells compared to DMSO-treated hypoxic H460 cells, virtually all of them are induced by prior hypoxia and most of these genes have been described in the literature as HIF-1 target genes
2012-12-08 | E-GEOD-42791 | biostudies-arrayexpress